US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS

376.37

+4.391.18%

Post-market: 375.00-1.3700-0.36%19:30 EDT

Volume:396.29K

Turnover:149.44M

Market Cap:42.91B

PE:67.34

High:380.00

Open:370.12

Low:369.49

Close:371.98

52wk High:385.22

52wk Low:253.95

Shares:114.00M

Float Shares:85.69M

Volume Ratio:1.04

T/O Rate:0.46%

Dividend:- -

Dividend Rate:- -

EPS(TTM):5.59

EPS(LYR):2.47

ROE:14.66%

ROA:7.46%

PB:8.29

PE(LYR):152.38

Loading ...

Overview Company News Filings

BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary

Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher

Beone Medicines Reports Record First Half Results with Adjusted Net Income Surge of 111%

GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B

MT Newswires Live

BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview

Is BeOne Medicines (ONC) Stock Priced For Perfection On Earnings?

Simply Wall St.

Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan

BeOne Medicines Targets Esophageal Cancer With New Tislelizumab Trial in Japan

Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish

Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks

BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market

BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing

MT Newswires Live

Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial

3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise

Simply Wall St.

Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5

BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes

Simply Wall St.

How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story

Simply Wall St.

BeOne Medicines (ONC) Gets a Buy from Barclays

BeOne Medicines Advances Sonrotoclax Formulation Study, Signaling Progress in ONC Pipeline

BeOne Medicines treatment of pancreatic cancer granted orphan status

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrdive.com/stock/ONC/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ONC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","market":"US","secType":"STK","nameCN":"BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS","latestPrice":376.37,"timestamp":1787688000000,"preClose":371.98,"halted":0,"volume":396290,"hourTrading":{"tag":"盘后","latestPrice":375,"preClose":376.37,"latestTime":"19:30 EDT","volume":50505,"amount":19007500.59,"timestamp":1787700602016,"change":-1.37,"changeRate":-0.00364,"amplitude":0.00364},"delay":0,"changeRate":0.011801709769342401,"floatShares":85693500,"shares":113999999,"eps":5.589356,"marketStatus":"Not Yet Opened","change":4.39,"latestTime":"08-25 16:00:00 EDT","open":370.12,"high":380,"low":369.49,"amount":149441771.39450002,"amplitude":0.028254,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":5.589356,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787731200000},"marketStatusCode":0,"adr":0,"adrRate":13,"exchange":"NASDAQ","adjPreClose":371.98,"preHourTrading":{"tag":"盘前","latestPrice":370.0447,"preClose":371.98,"latestTime":"06:09 EDT","volume":75,"amount":27721.1835,"timestamp":1787652598213,"change":-1.9353,"changeRate":-0.005203,"amplitude":0.001169},"postHourTrading":{"tag":"盘后","latestPrice":375,"preClose":376.37,"latestTime":"19:30 EDT","volume":50505,"amount":19007500.59,"timestamp":1787700602016,"change":-1.37,"changeRate":-0.00364,"amplitude":0.00364},"volumeRatio":1.037767,"impliedVol":0.3279,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ONC\",,,,,undefined,":{"symbol":"ONC","floatShares":85693500,"roa":"7.46%","roe":"14.66%","lyrEps":2.469999,"volumeRatio":1.037767,"shares":113999999,"dividePrice":0,"high":380,"amplitude":0.028254,"preClose":371.98,"low":369.49,"week52Low":253.9475,"pbRate":"8.29","psRate":"7.00","week52High":385.22,"institutionHeld":0,"latestPrice":376.37,"eps":5.589356,"divideRate":0,"volume":396290,"delay":0,"ttmEps":5.589356,"open":370.12,"prevYearClose":303.81,"prevWeekClose":374.47,"prevMonthClose":316.01,"prevQuarterClose":284.97,"fiveDayClose":369.15,"twentyDayClose":330.46,"sixtyDayClose":287.92},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ONC\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"ONC","fiscalQuarterEnding":"2026/06","expectedEps":1.4,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":2.05},{"market":"US","date":"2026-05-06","symbol":"ONC","fiscalQuarterEnding":"2026/03","expectedEps":0.73,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":1.96},{"market":"US","date":"2026-02-26","symbol":"ONC","fiscalQuarterEnding":"2025/12","expectedEps":1.6,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1772082000000,"reportTimeType":"pre","actualEps":0.58},{"market":"US","date":"2025-11-06","symbol":"ONC","fiscalQuarterEnding":"2025/09","expectedEps":0.72,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":1.09},{"date":"2025-08-30","symbol":"ONC","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1756540800000,"name":null,"time":"Pre-MKt","dateTimestamp":1756526400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ONC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ONC\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2857,"buy":0.6786,"hold":0,"sell":0.0357,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6786,"analysts":28,"updateTime":1783915200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ONC\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ONC","date":"2026-08-24","current":67.336917,"percent":0.723214,"low":-217.585346,"twenty":-72.8475,"median":-26.200046,"eighty":109.783513,"high":609.337035,"avg":44.101603,"sd":211.707426,"marketCap":42577941880},"quantilePoints":[{"date":"2024-05-31","current":-19.860847,"twenty":-20.46703,"median":-20.284421,"eighty":-20.042184,"marketCap":15579384952},{"date":"2024-06-07","current":-20.864085,"twenty":-20.930269,"median":-20.558927,"eighty":-20.042184,"marketCap":16366351618},{"date":"2024-06-14","current":-21.694058,"twenty":-21.409839,"median":-20.844737,"eighty":-20.30869,"marketCap":17017405001},{"date":"2024-06-21","current":-20.966373,"twenty":-21.331475,"median":-20.876952,"eighty":-20.46703,"marketCap":16446589390},{"date":"2024-06-28","current":-19.234246,"twenty":-21.331475,"median":-20.825389,"eighty":-19.981739,"marketCap":15087861974},{"date":"2024-07-05","current":-19.83401,"twenty":-21.208618,"median":-20.693442,"eighty":-19.760805,"marketCap":15558333278},{"date":"2024-07-12","current":-20.525989,"twenty":-21.135228,"median":-20.465877,"eighty":-19.641074,"marketCap":16101139655},{"date":"2024-07-19","current":-20.872652,"twenty":-21.016911,"median":-20.525989,"eighty":-19.707798,"marketCap":16373071895},{"date":"2024-07-26","current":-21.924783,"twenty":-21.374239,"median":-20.660298,"eighty":-19.760805,"marketCap":17198391533},{"date":"2024-08-02","current":-22.081827,"twenty":-21.704901,"median":-20.777003,"eighty":-19.839377,"marketCap":17321581561},{"date":"2024-08-09","current":-37.033118,"twenty":-22.009534,"median":-20.868368,"eighty":-19.874904,"marketCap":19394058972},{"date":"2024-08-16","current":-39.443432,"twenty":-22.36867,"median":-20.966373,"eighty":-19.937065,"marketCap":20656328240},{"date":"2024-08-23","current":-39.274234,"twenty":-33.284244,"median":-21.171036,"eighty":-20.00126,"marketCap":20567720015},{"date":"2024-08-30","current":-38.860864,"twenty":-37.912544,"median":-21.248991,"eighty":-20.190606,"marketCap":20351240040},{"date":"2024-09-06","current":-38.812817,"twenty":-38.506257,"median":-21.456019,"eighty":-20.300725,"marketCap":20326078245},{"date":"2024-09-13","current":-40.29759,"twenty":-38.865563,"median":-21.710093,"eighty":-20.355918,"marketCap":21103646159},{"date":"2024-09-20","current":-41.008162,"twenty":-39.353261,"median":-21.954664,"eighty":-20.405766,"marketCap":21475769498},{"date":"2024-09-27","current":-44.343793,"twenty":-39.883427,"median":-22.072098,"eighty":-20.507104,"marketCap":23222622772},{"date":"2024-10-04","current":-49.961787,"twenty":-40.117185,"median":-22.410559,"eighty":-20.525989,"marketCap":26164738255},{"date":"2024-10-11","current":-47.875901,"twenty":-40.317892,"median":-22.855632,"eighty":-20.558927,"marketCap":25072369873},{"date":"2024-10-18","current":-44.402313,"twenty":-41.008162,"median":-37.033118,"eighty":-20.627155,"marketCap":23253269086},{"date":"2024-10-25","current":-43.1532,"twenty":-43.068033,"median":-37.882149,"eighty":-20.693442,"marketCap":22599114920},{"date":"2024-11-01","current":-41.429716,"twenty":-43.148001,"median":-38.271158,"eighty":-20.724275,"marketCap":21696535276},{"date":"2024-11-08","current":-41.685343,"twenty":-43.068033,"median":-38.746669,"eighty":-20.777003,"marketCap":21830405481},{"date":"2024-11-15","current":-24.188369,"twenty":-42.835701,"median":-38.506257,"eighty":-20.825389,"marketCap":20104967290},{"date":"2024-11-22","current":-24.46985,"twenty":-42.494274,"median":-38.062423,"eighty":-20.864085,"marketCap":20240962418},{"date":"2024-11-29","current":-27.613239,"twenty":-42.262623,"median":-37.45966,"eighty":-20.870939,"marketCap":22851200825},{"date":"2024-12-06","current":-26.519964,"twenty":-42.078114,"median":-35.811244,"eighty":-20.886386,"marketCap":21862847938},{"date":"2024-12-13","current":-23.158686,"twenty":-41.984053,"median":-26.690447,"eighty":-20.951062,"marketCap":19077141333},{"date":"2024-12-20","current":-22.876382,"twenty":-41.961072,"median":-26.519964,"eighty":-21.016911,"marketCap":18791641889},{"date":"2024-12-27","current":-23.581122,"twenty":-41.848457,"median":-25.970587,"eighty":-21.108807,"marketCap":19365505627},{"date":"2025-01-03","current":-23.522344,"twenty":-41.738903,"median":-25.015322,"eighty":-21.169159,"marketCap":19262068568},{"date":"2025-01-10","current":-23.039426,"twenty":-41.667895,"median":-24.95255,"eighty":-21.188412,"marketCap":18831625271},{"date":"2025-01-17","current":-27.361812,"twenty":-41.564427,"median":-24.990614,"eighty":-21.226086,"marketCap":22387798297},{"date":"2025-01-24","current":-28.60727,"twenty":-41.429716,"median":-25.817461,"eighty":-21.248991,"marketCap":23666613889},{"date":"2025-01-31","current":-29.006926,"twenty":-41.129457,"median":-26.292693,"eighty":-21.405551,"marketCap":23976726670},{"date":"2025-02-07","current":-29.003485,"twenty":-41.095232,"median":-26.532547,"eighty":-21.456019,"marketCap":23849552911},{"date":"2025-02-14","current":-29.812673,"twenty":-41.008162,"median":-26.754345,"eighty":-21.694058,"marketCap":24634934161},{"date":"2025-02-21","current":-32.964646,"twenty":-40.974605,"median":-27.361812,"eighty":-21.704901,"marketCap":27250381776},{"date":"2025-02-28","current":-45.085214,"twenty":-41.025576,"median":-28.423545,"eighty":-21.711581,"marketCap":29070314911},{"date":"2025-03-07","current":-41.087466,"twenty":-41.189509,"median":-28.729221,"eighty":-21.882341,"marketCap":26492622821},{"date":"2025-03-14","current":-43.209977,"twenty":-41.608729,"median":-28.790129,"eighty":-21.948688,"marketCap":27861188167},{"date":"2025-03-21","current":-42.024306,"twenty":-41.961072,"median":-29.003485,"eighty":-22.009534,"marketCap":27096684166},{"date":"2025-03-28","current":-44.59433,"twenty":-42.028738,"median":-29.052749,"eighty":-22.054545,"marketCap":28753799426},{"date":"2025-04-04","current":-39.846019,"twenty":-42.270172,"median":-29.231496,"eighty":-22.077935,"marketCap":25692155286},{"date":"2025-04-11","current":-38.484462,"twenty":-42.209323,"median":-29.379987,"eighty":-22.177258,"marketCap":24814242135},{"date":"2025-04-17","current":-38.603,"twenty":-42.109763,"median":-29.75631,"eighty":-22.326782,"marketCap":24890673891},{"date":"2025-04-25","current":-40.929408,"twenty":-42.213935,"median":-30.85745,"eighty":-22.4234,"marketCap":26390709308},{"date":"2025-05-02","current":-42.799955,"twenty":-42.322726,"median":-33.161649,"eighty":-22.493794,"marketCap":27596811853},{"date":"2025-05-09","current":-63.824658,"twenty":-42.611855,"median":-33.528671,"eighty":-22.601969,"marketCap":25042625921},{"date":"2025-05-16","current":-62.94985,"twenty":-42.804476,"median":-34.892623,"eighty":-22.71748,"marketCap":24699380815},{"date":"2025-05-23","current":-72.041871,"twenty":-43.150081,"median":-36.84391,"eighty":-22.787779,"marketCap":28266780880},{"date":"2025-05-30","current":-74.527648,"twenty":-43.429182,"median":-37.087829,"eighty":-22.808465,"marketCap":29242115209},{"date":"2025-06-06","current":-77.688492,"twenty":-43.794804,"median":-38.030583,"eighty":-22.84042,"marketCap":30482322820},{"date":"2025-06-13","current":-89.808695,"twenty":-44.177303,"median":-38.271158,"eighty":-22.941372,"marketCap":35237878321},{"date":"2025-06-20","current":-76.439732,"twenty":-44.40516,"median":-38.484462,"eighty":-23.038971,"marketCap":29992352055},{"date":"2025-06-27","current":-76.95683,"twenty":-44.800569,"median":-38.641761,"eighty":-23.063278,"marketCap":30195243589},{"date":"2025-07-03","current":-74.11053,"twenty":-45.138397,"median":-38.836841,"eighty":-23.158686,"marketCap":29078452032},{"date":"2025-07-11","current":-76.495446,"twenty":-45.905367,"median":-39.006759,"eighty":-23.171606,"marketCap":30014212230},{"date":"2025-07-18","current":-87.653233,"twenty":-47.435675,"median":-39.313748,"eighty":-23.176246,"marketCap":34392148550},{"date":"2025-07-25","current":-89.648478,"twenty":-48.541013,"median":-39.640999,"eighty":-23.189441,"marketCap":35175014575},{"date":"2025-08-01","current":-91.060669,"twenty":-60.626235,"median":-39.865155,"eighty":-23.250607,"marketCap":35729110635},{"date":"2025-08-08","current":-184.757225,"twenty":-63.824658,"median":-40.051934,"eighty":-23.50984,"marketCap":32820458238},{"date":"2025-08-15","current":-191.818248,"twenty":-64.911375,"median":-40.112152,"eighty":-23.522344,"marketCap":34074785315},{"date":"2025-08-22","current":-194.469228,"twenty":-72.041871,"median":-40.222554,"eighty":-23.535152,"marketCap":34545708113},{"date":"2025-08-29","current":-184.552827,"twenty":-72.8475,"median":-40.343171,"eighty":-23.581122,"marketCap":32784148770},{"date":"2025-09-05","current":-197.417514,"twenty":-73.864189,"median":-40.425269,"eighty":-23.723244,"marketCap":35069444682},{"date":"2025-09-12","current":-208.147892,"twenty":-74.224679,"median":-40.801852,"eighty":-23.82061,"marketCap":36975599617},{"date":"2025-09-19","current":-212.503459,"twenty":-75.66857,"median":-40.932054,"eighty":-23.865007,"marketCap":37749326897},{"date":"2025-09-26","current":-203.715512,"twenty":-76.587723,"median":-41.008162,"eighty":-23.928977,"marketCap":36188227257},{"date":"2025-10-03","current":-213.916471,"twenty":-77.910534,"median":-41.112345,"eighty":-23.950329,"marketCap":38000335866},{"date":"2025-10-10","current":-208.109485,"twenty":-81.639564,"median":-41.598105,"eighty":-24.044918,"marketCap":36968777077},{"date":"2025-10-17","current":-197.090466,"twenty":-85.2662,"median":-41.668284,"eighty":-24.084563,"marketCap":35011347487},{"date":"2025-10-24","current":-192.138725,"twenty":-87.584871,"median":-41.753651,"eighty":-24.09529,"marketCap":34131715179},{"date":"2025-10-31","current":-191.016991,"twenty":-89.061223,"median":-41.811067,"eighty":-24.120226,"marketCap":33932449287},{"date":"2025-11-07","current":-207.03708,"twenty":-89.680521,"median":-41.96845,"eighty":-24.175905,"marketCap":36778273935},{"date":"2025-11-14","current":594.631071,"twenty":-89.43801,"median":-41.811067,"eighty":-24.044918,"marketCap":40761959883},{"date":"2025-11-21","current":563.847015,"twenty":-89.201535,"median":-41.753651,"eighty":-23.82061,"marketCap":38651712910},{"date":"2025-11-28","current":549.835185,"twenty":-89.104768,"median":-41.685343,"eighty":-23.530029,"marketCap":37691201965},{"date":"2025-12-05","current":534.967794,"twenty":-89.063642,"median":-41.61723,"eighty":-23.184163,"marketCap":36672042310},{"date":"2025-12-12","current":517.921144,"twenty":-88.590694,"median":-41.129457,"eighty":-23.039198,"marketCap":35503494432},{"date":"2025-12-19","current":495.611986,"twenty":-88.19516,"median":-41.047814,"eighty":-22.787779,"marketCap":33974201659},{"date":"2025-12-26","current":503.21518,"twenty":-87.945005,"median":-40.950457,"eighty":-22.473183,"marketCap":34495400571},{"date":"2026-01-02","current":490.430192,"twenty":-87.636143,"median":-40.899758,"eighty":-22.105685,"marketCap":33618989662},{"date":"2026-01-09","current":517.162439,"twenty":-87.22937,"median":-40.570085,"eighty":-21.930759,"marketCap":35451485198},{"date":"2026-01-16","current":546.090088,"twenty":-85.828543,"median":-40.382553,"eighty":-21.503627,"marketCap":37434475537},{"date":"2026-01-23","current":546.929506,"twenty":-85.639801,"median":-40.307741,"eighty":-21.22036,"marketCap":37492017667},{"date":"2026-01-30","current":564.993144,"twenty":-85.550958,"median":-40.153659,"eighty":-20.966373,"marketCap":38730280050},{"date":"2026-02-06","current":560.150346,"twenty":-85.195011,"median":-40.102874,"eighty":-20.825389,"marketCap":38398306221},{"date":"2026-02-13","current":559.214072,"twenty":-84.275105,"median":-39.916618,"eighty":-20.627155,"marketCap":38334124614},{"date":"2026-02-20","current":572.225057,"twenty":-83.309792,"median":-39.846883,"eighty":-20.486836,"marketCap":39226027634},{"date":"2026-02-27","current":124.64483,"twenty":-82.630374,"median":-39.542215,"eighty":-20.122622,"marketCap":35764714896},{"date":"2026-03-06","current":113.265677,"twenty":-81.639564,"median":-39.274234,"eighty":-19.815709,"marketCap":32499660582},{"date":"2026-03-13","current":110.254986,"twenty":-80.905934,"median":-38.936161,"eighty":-19.52935,"marketCap":31635793773},{"date":"2026-03-20","current":109.257937,"twenty":-80.698984,"median":-38.812817,"eighty":-19.378455,"marketCap":31349707731},{"date":"2026-03-27","current":107.028105,"twenty":-78.593786,"median":-38.554628,"eighty":106.63856,"marketCap":30709895147},{"date":"2026-04-02","current":119.197503,"twenty":-77.951,"median":-38.396659,"eighty":109.305857,"marketCap":34201697271},{"date":"2026-04-10","current":121.122038,"twenty":-77.761122,"median":-38.192039,"eighty":109.972102,"marketCap":34753909865},{"date":"2026-04-17","current":123.949552,"twenty":-77.38927,"median":-37.882149,"eighty":113.865362,"marketCap":35565216938},{"date":"2026-04-24","current":115.875632,"twenty":-77.050014,"median":-37.033118,"eighty":115.720164,"marketCap":33248542844},{"date":"2026-05-01","current":114.357667,"twenty":-76.68,"median":-35.397875,"eighty":115.720164,"marketCap":32812988374},{"date":"2026-05-08","current":68.695502,"twenty":-76.462018,"median":-34.468285,"eighty":115.560959,"marketCap":35242166242},{"date":"2026-05-15","current":66.012693,"twenty":-76.246744,"median":-33.418249,"eighty":115.518333,"marketCap":33865831800},{"date":"2026-05-22","current":67.096218,"twenty":-76.102676,"median":-31.546239,"eighty":115.492019,"marketCap":34421701930},{"date":"2026-05-29","current":62.970154,"twenty":-75.880486,"median":-30.693232,"eighty":115.373164,"marketCap":32304948475},{"date":"2026-06-05","current":60.662245,"twenty":-75.223997,"median":-29.59006,"eighty":115.163248,"marketCap":31120945098},{"date":"2026-06-12","current":56.401824,"twenty":-74.640704,"median":-29.253094,"eighty":114.989528,"marketCap":28935263747},{"date":"2026-06-18","current":56.924083,"twenty":-74.490547,"median":-29.223519,"eighty":114.833736,"marketCap":29203193149},{"date":"2026-06-26","current":59.667569,"twenty":-74.312777,"median":-29.026044,"eighty":114.683445,"marketCap":30610656318},{"date":"2026-07-02","current":63.004827,"twenty":-74.195313,"median":-28.914242,"eighty":114.357667,"marketCap":32322736319},{"date":"2026-07-10","current":65.624791,"twenty":-74.135535,"median":-28.781271,"eighty":113.811576,"marketCap":33666830293},{"date":"2026-07-17","current":68.786518,"twenty":-74.11053,"median":-28.668245,"eighty":113.265677,"marketCap":35288859332},{"date":"2026-07-24","current":70.81271,"twenty":-74.11053,"median":-28.275697,"eighty":112.626442,"marketCap":36328336476},{"date":"2026-07-31","current":69.796363,"twenty":-73.864189,"median":-27.361812,"eighty":112.074132,"marketCap":35806930294},{"date":"2026-08-07","current":57.188468,"twenty":-73.321375,"median":-26.690447,"eighty":111.218799,"marketCap":37498879034},{"date":"2026-08-14","current":61.733374,"twenty":-72.9906,"median":-26.519964,"eighty":110.411886,"marketCap":40479005230},{"date":"2026-08-21","current":64.013629,"twenty":-72.865597,"median":-26.24637,"eighty":109.877808,"marketCap":41974184913},{"date":"2026-08-24","current":64.934402,"twenty":-72.8475,"median":-26.200046,"eighty":109.783513,"marketCap":42577941880}],"updateTime":1787700577129},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ONC\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657549227","title":"BeOne Medicines AG Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657549227","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657549227?lang=en_us&edition=fundamental","pubTime":"2026-08-05 19:36","pubTimestamp":1785929784,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG reports results for the quarter ended June 30 - Earnings SummaryBeOne Medicines AGONC.OQreported quarterly adjusted earnings of $2.05 per share for the quarter ended June 30, higher","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL8N4421LK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC","BK4588","BK4526","BK4139","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116587955","title":"Beone Medicines Reports Record Q2 Revenue Surge and Skyrocketing Profits, Revises 2026 Full-Year Guidance Higher","url":"https://stock-news.laohu8.com/highlight/detail?id=1116587955","media":"Deep News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116587955?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:28","pubTimestamp":1785925729,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd. delivered a strong second-quarter performance, with its core commercial products continuing to expand. The company's revenue, profits, and cash flow all improved simultaneously,...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1588","LU1719994722.HKD","LU1770034418.SGD","KURE","06160","BK4588","BK4526","BK4139","ONC","LU1969619763.USD","LU1251922891.USD","LU0588546209.SGD","BK1500","BK1161","BK4585","LU1303224171.USD","BK0239","BK1583","LU2328871848.SGD","LU0307460666.USD","688235"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138012620","title":"Beone Medicines Reports Record First Half Results with Adjusted Net Income Surge of 111%","url":"https://stock-news.laohu8.com/highlight/detail?id=1138012620","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138012620?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:18","pubTimestamp":1785925103,"startTime":"0","endTime":"0","summary":"Beone Medicines Ltd (stock code: 06160) has released its financial results for the second quarter of fiscal year 2026, showcasing robust performance. For the second quarter, the company's global...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KURE","BK1500","BK1161","06160","LU1719994722.HKD","BK1588","LU1969619763.USD","LU1770034418.SGD","LU1251922891.USD","BK4585","BK0239","BK4139","LU0307460666.USD","LU1303224171.USD","BK1583","BK4588","688235","ONC","LU2328871848.SGD","LU0588546209.SGD","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657510243","title":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B","url":"https://stock-news.laohu8.com/highlight/detail?id=2657510243","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657510243?lang=en_us&edition=fundamental","pubTime":"2026-08-05 18:03","pubTimestamp":1785924210,"startTime":"0","endTime":"0","summary":"GUIDANCE: (ONC) BeOne Medicines Expects 2026 Revenue Range $6.6B to $6.8B, vs. FactSet Est of $6.51B","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656321864","title":"BeOne Medicines AG Expected to Post Earnings of $1.58 a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656321864","media":"Reuters","labels":["preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656321864?lang=en_us&edition=fundamental","pubTime":"2026-08-03 16:05","pubTimestamp":1785744305,"startTime":"0","endTime":"0","summary":"BeOne Medicines AG <ONC.OQ> expected to post earnings of $1.58 a share - Earnings PreviewBeOne Medicines AGONC.OQ,ONC.Ois expected to  show a rise in quarterly revenue when it reports  results on Augu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N4400GG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4526","BK4585","ONC","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655746888","title":"Is BeOne Medicines (ONC) Stock Priced For Perfection On Earnings?","url":"https://stock-news.laohu8.com/highlight/detail?id=2655746888","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655746888?lang=en_us&edition=fundamental","pubTime":"2026-07-30 19:17","pubTimestamp":1785410238,"startTime":"0","endTime":"0","summary":"BeOne Medicines stock has delivered a 59.0% return over the past three years, yet the current checks flag it as screening on the expensive side rather than as an obvious bargain.\n\nBeOne Medicines has returned 59.0% over three years, which puts extra focus on whether the current share price still leaves enough value support for new investors.\nFuture revenue and cash flow expectations can support the current valuation, while any setback in execution or higher funding needs could quickly reduce...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-stock-priced-for-perfection-on-earnin","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/is-beone-medicines-onc-stock-priced-for-perfection-on-earnin","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130711808","title":"Beigene Issues 866,100 New Shares Under Employee Stock Purchase Plan","url":"https://stock-news.laohu8.com/highlight/detail?id=1130711808","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130711808?lang=en_us&edition=fundamental","pubTime":"2026-07-30 18:06","pubTimestamp":1785406019,"startTime":"0","endTime":"0","summary":"Beigene Ltd (HKEX: 06160) has announced a capital increase through the issuance of 866,100 new shares to its wholly-owned subsidiary, BGNC2.This move is authorized under the company's Swiss Articles...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1303224171.USD","BK1161","BK1500","LU1969619763.USD","BK1583","LU1770034418.SGD","LU0307460666.USD","LU1251922891.USD","688235","LU0588546209.SGD","BK0239","LU1719994722.HKD","BK1588","06160","BK4139","ONC","KURE","BK4526","BK4585","BK4588","LU2328871848.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655978928","title":"BeOne Medicines Targets Esophageal Cancer With New Tislelizumab Trial in Japan","url":"https://stock-news.laohu8.com/highlight/detail?id=2655978928","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655978928?lang=en_us&edition=fundamental","pubTime":"2026-07-30 00:31","pubTimestamp":1785342709,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines (ONC) is launching a Phase 2 study in Japan to test dif...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-targets-esophageal-cancer-with-new-tislelizumab-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-targets-esophageal-cancer-with-new-tislelizumab-trial-in-japan?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MDCO","BK4139","BK4585","BK4526","BK4588","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1197431874","title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish","url":"https://stock-news.laohu8.com/highlight/detail?id=1197431874","media":"Earnings Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1197431874?lang=en_us&edition=fundamental","pubTime":"2026-07-29 17:11","pubTimestamp":1785316319,"startTime":"0","endTime":"0","summary":"Abstract BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS will post results on August 05, 2026 Post Market; this preview summarizes last quarter’s performance, breaks down segment trends, and highlights...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Earning Preview: BEIGENE LTD SPON ADS EACH REPR 13 ORD SHS revenue is expected to increase by 29%, and institutional views are bullish","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1192093154","title":"Hong Kong Stock Market Analysis: ChangXin IPO Pressure Weighs, Agricultural Inflation Risks Boost Related Stocks","url":"https://stock-news.laohu8.com/highlight/detail?id=1192093154","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1192093154?lang=en_us&edition=fundamental","pubTime":"2026-07-24 20:24","pubTimestamp":1784895881,"startTime":"0","endTime":"0","summary":"The market faced significant headwinds as the heavyweight ChangXin Technology is set to list on the Shanghai Stock Exchange's STAR Market on July 27. Today, A-share turnover fell below 2 trillion...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0501845795.SGD","00175","LU1282651121.HKD","LU1642822792.SGD","IE00BZ08YT58.USD","LU0708995583.HKD","LU1960683339.HKD","LU1008478684.HKD","688981","LU0320764599.SGD","02218","BK1119","BK1553","BK1601","LU0955669360.SGD","LU0417516738.SGD","LU1282651048.USD","LU0163747925.USD","LU0314109678.HKD","BK1212","LU1224444064.USD","HK0000165453.HKD","688235","BK1526","06160","BHKLY","ONC","SG9999014674.SGD","LU0149534421.HKD","LU1211504680.USD","BK1614","IE00BGHQDM52.EUR","BK1607","BK1129","LU0315179316.USD","BK1231","BK1572","LU1044874839.SGD","LU1226288170.HKD","LU0516423091.SGD","LU1226288253.USD","IE00BVYPNP33.GBP","BK1610","00189","IE00BVYPNQ40.USD","LU0414403682.SGD","LU1813983027.USD","09863","00981","BK1511","LU1044875133.USD","LU1251922891.USD","605198","01117","SG9999002828.SGD","LU0228367735.SGD","BK1117","IE0008369823.USD","LU0140636845.USD","LU1130305938.SGD","BK1588","LU1328277881.USD","LU1861219969.SGD","LU2039709279.SGD","LU0348735423.USD","LU1226287792.SGD","LU1328615791.USD","IE0008368742.USD","06613","BK1539","BK1594","03986","LU1044876610.USD","BK1515","BK1587","SG9999004220.SGD","LU0880133367.SGD","LU1226287529.USD","IE00B031HY20.USD","LU0052750758.USD","LU1023057109.AUD","KURE","IE00BZ08YR35.GBP","LU0588546209.SGD","603986","LU0359201885.HKD","00023","BK1163","LU0738912210.USD","BK1521","LU1152091754.HKD","LU0067412154.USD","LU0516422440.USD","BK1507","BK1616","LU2360107325.USD","LU1951186391.HKD","LU0516422366.SGD","LU1807302812.USD","BK1589","BK1560","LU1993786604.SGD","LU1152091168.USD","BKEAY","LU1770034418.SGD","06809","02356","IE00B543WZ88.USD","LU1303224171.USD","80175","LU0593848301.USD","LU1226287875.USD","02388","82388","02513","01093","EVS.SI","BK1161","LU1719994722.HKD","IE00BZ08YS42.EUR","BK1191","LU0516423174.USD","LU1861214812.USD","LU0293314216.USD","BK1237","IE00B0JY6N72.USD","BK1522","BK1170","LU0307460666.USD","LU0072913022.USD","GELYY","300433","LU0359201612.USD","LU1969619763.USD","BK1233","02589","LU0359202008.SGD","LU0955648018.USD","LU2328871848.SGD","LU0955623706.USD","LU0326950275.SGD","BK1500","BK1583","03143","688008","LU0607220059.USD","LU0516422952.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1145338164","title":"BeiGene Invests Additional $300 Million in US Expansion, Stock Hits 3-Month High; Hong Kong Stock Connect Innovative Drugs Show Local Strength, 520880 Rises for Third Consecutive Day Against Market","url":"https://stock-news.laohu8.com/highlight/detail?id=1145338164","media":"Deep News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1145338164?lang=en_us&edition=fundamental","pubTime":"2026-07-24 10:12","pubTimestamp":1784859132,"startTime":"0","endTime":"0","summary":"On July 24th, Hong Kong stocks fell again, with the Hang Seng Index dropping over 1%. Pharmaceutical stocks bucked the trend and moved higher, with innovative drug leaders pushing upward once more....","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBBQ","ONC","BK1588","LU1969619763.USD","LU1251922891.USD","520880","06978","LU0307460666.USD","KURE","LNGR","BK4585","159992","BK1500","BK4139","LU1770034418.SGD","06160","688235","LU1303224171.USD","BK1583","BK1574","MEDX","BK4588","BK1161","LU2328871848.SGD","BK4526","BK0239","LU1719994722.HKD","LU0588546209.SGD","FLHK"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653293727","title":"BeOne Medicines to Invest $300 Million to Expand US Drug Manufacturing","url":"https://stock-news.laohu8.com/highlight/detail?id=2653293727","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653293727?lang=en_us&edition=fundamental","pubTime":"2026-07-23 22:30","pubTimestamp":1784817036,"startTime":"0","endTime":"0","summary":"BeOne Medicines  said Thursday it plans to invest $300 million to expand its flagship clinical and commercial-stage manufacturing and research and development center at the Princeton West Innovation Campus in Hopewell, New Jersey.The expansion will advance BeOne's oncology pipeline of more than 35 clinical and commercial-stage assets, the company said.The investment will fund the construction of a new three-story, 145,000-square-foot building near BeOne's existing Hopewell facilities, increasing the total campus footprint to about 545,000 square feet, the company added.Price: 322.62, Change: +2.69, Percent Change: +0.84","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ONC","BK4139","MDCO","BK4585","BK4588","BK4526"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172822449","title":"Amgen and BeiGene Advance Subcutaneous Formulation of FIC Bispecific Antibody into Phase III Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=1172822449","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172822449?lang=en_us&edition=fundamental","pubTime":"2026-07-23 20:11","pubTimestamp":1784808697,"startTime":"0","endTime":"0","summary":"On July 22nd, a clinical trial registration platform showed that Amgen and BeiGene jointly registered a Phase III study, DeLLphi-315, comparing subcutaneous versus intravenous administration of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJJMRZ35.SGD","LU1571399168.USD","LU2112291526.USD","LU1057294990.SGD","06160","IE00BJT1NW94.SGD","IE00B2B36J28.USD","BK4599","LU2242652126.USD","LU1303224171.USD","IE0009355771.USD","BIB","KURE","BK4134","IBBQ","BBH","LU2468319806.SGD","688235","LU0122379950.USD","PBE","BK4566","LU1770034418.SGD","BK1161","LU0320765992.SGD","LU2089984988.USD","LU0868494617.USD","BK4581","LU1969619763.USD","LU0058720904.USD","LU1061106388.HKD","LU1719994722.HKD","BK1588","BK4526","BK4534","LU0109394709.USD","AMGN","IE00B4R5TH58.HKD","LU1023059063.AUD","LU1983299246.USD","LU2242646821.SGD","SG9999001440.SGD","III","BK1500","LU0289739699.SGD","LU0889565916.HKD","TBXU","IE00BFTCPJ56.SGD","BK1583","BK4585","BK4588","IBB","LU0588546209.SGD","LU2328871848.SGD","ONC","BK4139","PJP","IE0002141913.USD","BK4533","LU0307460666.USD","BK0239","LU1251922891.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653353147","title":"3 U.S. Drug Manufacturing Stocks Investors Are Watching As Tariffs Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2653353147","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653353147?lang=en_us&edition=fundamental","pubTime":"2026-07-22 11:30","pubTimestamp":1784691011,"startTime":"0","endTime":"0","summary":"Tariffs on imported generic drugs are set to rise sharply over the next few years, and that kind of policy shock rarely stays contained to one corner of the market. For investors, the question is which U.S. pharmaceutical and biotech manufacturing stocks might stand to benefit if production shifts closer to home, and which could face new pressures through supply chain or pricing risks. This article looks at how the new tariff path could affect larger domestic drug manufacturers and contract...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/3-us-drug-manufacturing-stocks-investors-are-watching-as-tar","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ONC","BK4526","BK4585","BK4007","ISBC","BK4139","BLTE","ADMA","BK4588","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2652139404","title":"Press Release: Beone Medicines to Announce Second Quarter 2026 Financial Results on August 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2652139404","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2652139404?lang=en_us&edition=fundamental","pubTime":"2026-07-17 18:02","pubTimestamp":1784282520,"startTime":"0","endTime":"0","summary":"SAN CARLOS, Calif.--(BUSINESS WIRE)--July 17, 2026--BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, will report its second quarter 2026 financial results on We","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4526","MDCO","ONC","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651544933","title":"BeOne Medicines (ONC) Stock Looks Expensive Even With Strong Pipeline Hopes","url":"https://stock-news.laohu8.com/highlight/detail?id=2651544933","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651544933?lang=en_us&edition=fundamental","pubTime":"2026-07-16 18:33","pubTimestamp":1784198003,"startTime":"0","endTime":"0","summary":"BeOne Medicines has delivered a 61.1% return over the past three years, yet its current valuation screens as overvalued on market multiples and only middling on broader checks. This raises the question of how much optimism is already reflected in the share price.\n\nA 61.1% three year return suggests investors have already priced in a meaningful amount of good news for BeOne Medicines.\nRecent analyst upgrades tied to the chronic lymphocytic leukemia franchise and solid tumor pipeline can...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-stock-looks-expensive-even-with-strong-p","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/beone-medicines-onc-stock-looks-expensive-even-with-strong-p","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ONC","BK4588","BK4526","BK4139","MDCO","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651482014","title":"How Chemotherapy-Free Phase 3 MCL Success At BeOne Medicines (ONC) Has Changed Its Investment Story","url":"https://stock-news.laohu8.com/highlight/detail?id=2651482014","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651482014?lang=en_us&edition=fundamental","pubTime":"2026-07-15 05:23","pubTimestamp":1784064190,"startTime":"0","endTime":"0","summary":"BeOne Medicines Ltd. recently reported positive topline results from its Phase 3 MANGROVE trial, where BRUKINSA (zanubrutinib) plus rituximab significantly improved progression-free survival versus bendamustine plus rituximab in previously untreated mantle cell lymphoma.\nThis is the first global Phase 3 study to show a chemotherapy-free, rituximab maintenance-free regimen can match or exceed standard chemoimmunotherapy, potentially sparing patients around two years of infusion treatment...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/how-chemotherapy-free-phase-3-mcl-success-at-beone-medicines","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-onc/beone-medicines/news/how-chemotherapy-free-phase-3-mcl-success-at-beone-medicines","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4588","BK4526","MDCO","BK4139","ONC","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2651150175","title":"BeOne Medicines (ONC) Gets a Buy from Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2651150175","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2651150175?lang=en_us&edition=fundamental","pubTime":"2026-07-14 16:37","pubTimestamp":1784018241,"startTime":"0","endTime":"0","summary":"In a report released today, Etzer Darout from Barclays maintained a Buy rating on BeOne Medicines, with a price target of $403.00. Darout covers th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-gets-a-buy-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/beone-medicines-onc-gets-a-buy-from-barclays-blurbs-news-3?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","BK4588","BK4585","BK4526","MDCO","ONC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650750489","title":"BeOne Medicines Advances Sonrotoclax Formulation Study, Signaling Progress in ONC Pipeline","url":"https://stock-news.laohu8.com/highlight/detail?id=2650750489","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650750489?lang=en_us&edition=fundamental","pubTime":"2026-07-10 00:31","pubTimestamp":1783614692,"startTime":"0","endTime":"0","summary":"BeOne Medicines ($ONC) announced an update on their ongoing clinical study. BeOne Medicines is running a Phase 1 study in healthy adults to test ho...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-sonrotoclax-formulation-study-signaling-progress-in-onc-pipeline?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/beone-medicines-advances-sonrotoclax-formulation-study-signaling-progress-in-onc-pipeline?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","BK4139","BK4526","PRGS","LU2065732104.USD","MDCO","ONC","BK4097","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650978219","title":"BeOne Medicines treatment of pancreatic cancer granted orphan status","url":"https://stock-news.laohu8.com/highlight/detail?id=2650978219","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650978219?lang=en_us&edition=fundamental","pubTime":"2026-07-09 23:00","pubTimestamp":1783609213,"startTime":"0","endTime":"0","summary":"BeOne Medicines (ONC)’ MTA-cooperative PRMT5 inhibitor was granted FDA orphan designation as a treatment of pancreatic cancer, according to a post ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/beone-medicines-treatment-of-pancreatic-cancer-granted-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/beone-medicines-treatment-of-pancreatic-cancer-granted-orphan-status-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4585","BK4588","BK4139","BK4526","ONC","LABU","MDCO"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":144,"code":"91000000","status":"200"}]}}